| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 2004;25:449-455
© 2004 Elsevier Science NL
a Department of Thoracic Surgery, School of Medicine, Sainte Marguerite Hospital, Université de la Méditerranée (Aix-Marseille II), Marseille, France
b Department of Thoracic Oncology, School of Medicine, Sainte Marguerite Hospital, Université de la Méditerranée (Aix-Marseille II), Marseille, France
c Department of Pathology, School of Medicine, Sainte Marguerite Hospital, Université de la Méditerranée (Aix-Marseille II), Marseille, France
d Assistance Publique, Hôpitaux de Marseille, UPRES EA 2201, IFR Jean Roche, Marseille, France
Received 17 August 2003; received in revised form 26 November 2003; accepted 1 December 2003.
* Corresponding author. Address: Department of Thoracic Surgery, School of Medicine, Sainte Marguerite Hospital, Université de la Méditerranée (Aix-Marseille II), CHU Sud, 270 Blvd, Sainte Marguerite, F-13274 Marseille Cedex 9, France. Tel.: +33-491-744-680; fax: +33-491-744-590
e-mail: pascal-alexandre.thomas{at}mail.ap-hm.fr
Objective: Analysis of a single institution experience with completion pneumonectomy. Methods: From 1989 to 2002, 55 consecutive cancer patients received completion pneumonectomy (mean age 62 years; 25–79). Indications were bronchogenic carcinoma in 38 patients (4 first cancers, 8 recurrent cancers, 26 second cancers), lung metastases in three (one each from breast cancer, colorectal neoplasm and lung cancer), lung sarcoma in one, and miscellaneous non-malignant conditions in 13 patients having been surgically treated for a non-small cell lung cancer previously (bronchopleural fistula in 4, radionecrosis in 3, aspergilloma in 2, pachypleura in 1, massive hemoptysis in 1 and pneumonia in 2). Before completion pneumonectomy, 50 patients had had a lobectomy, three a bilobectomy, and two lesser resections. The mean interval between the two procedures was 51 months for the whole group (1–469), 60 months for lung cancer (12–469), 43 months for pulmonary metastases (21–59) and 29 months for non-malignant disorders (1–126). Results: There were 35 right (64%) and 20 left (36%) resections. The surgical approaches were a posterolateral thoracotomy in 50 cases (91%) and a lateral thoracotomy in five cases (9%). Intrapericardial route was used in 49 patients (89%). Five patients had an extended resection (2 chest wall, 1 diaphragm, 1 subclavian artery and 1 superior vena cava). Operative mortality was 16.4% (n=9): 11.9% for malignant disease (n=5) and 30.8% for benign disease (n=4). Operative mortality was 20% for right completion pneumonectomies (n=7) and 10% for left-sided procedures (n=2). Twenty-three patients (42%) experienced non-fatal major complications. Actuarial 3- and 5-year survival rates from the time of completion pneumonectomy were 48.4 and 35.2% for the entire group. Three- and five-year survival for patients with bronchogenic carcinoma were 56.9 and 43.4%, respectively. Conclusions: These results suggest that completion pneumonectomy in the setting of lung malignancies can be done with an operative risk similar to the one reported for standard pneumonectomy. In contrast, in cancer patients, completion pneumonectomy for inflammatory disorders is a very high-risk procedure.
Key Words: Completion pneumonectomy • Lung cancer • Operative risk • Long-term survival
This article has been cited by other articles:
|
|
 |
|
  O. Chataigner, E. Fadel, B. Yildizeli, A. Achir, S. Mussot, D. Fabre, O. Mercier, and P. G. Dartevelle Factors affecting early and long-term outcomes after completion pneumonectomy Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 837 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nakanishi, A. Hirai, T. Yamashita, and S. Oka Video-assisted thoracoscopic completion pneumonectomy for a second primary cancer: A case report. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 945 - 946. [Full Text] [PDF]
|
|
|
|
|
|
H. Iwata, T. Kiryu, K. Shirahashi, S. Matsumoto, M. Matsui, and H. Takemura Right lower lobectomy after right upper lobectomy for multiple metastases in lung cancer of the right lower lobe: Benefit of middle lobe preservation. J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 1078 - 1080. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
